Genmab | GEN - Current Assets


Genmab reported DKK2.88B in Current Assets for its fiscal quarter ending in December of 2025.





Current Assets Change Date
Agios Pharmaceuticals USD 942.05M 91.06M Dec/2025
Almirall EUR 713.98M 69K Dec/2025
Amarin USD 649.88M 21.55M Dec/2025
Amgen USD 29.06B 1.17B Dec/2025
argenx SE USD 5.83B 946.64M Jun/2025
AstraZeneca USD 28.72B 1.22B Dec/2025
Bayer EUR 32.91B 30M Dec/2025
BioMarin Pharmaceutical USD 3.95B 98.95M Dec/2025
Demant DKK 10.08B 128M Dec/2025
Exelixis USD 1.44B 41.03M Dec/2025
Fresenius Medical Care EUR 7.9B 74M Dec/2025
Galapagos EUR 3.08B 82.56M Dec/2025
Genmab DKK 2.88B 1.59B Dec/2025
GlaxoSmithKline GBP 17.51B 332M Dec/2025
GN Store Nord DKK 8.64B 105M Dec/2025
GRIFOLS EUR 5.07B 274.77M Dec/2025
Hikma Pharmaceutical USD 2.64B 86M Dec/2025
Insmed USD 1.79B 137.6M Dec/2025
Lonza CHF 8B 3.41B Dec/2025
Merck EUR 13.23B 354M Dec/2025
Novartis USD 30.46B 2.26B Dec/2025
Regeneron Pharmaceuticals USD 18.02B 41.2M Dec/2025
Roche Holding CHF 38.73B 3.03B Dec/2025
Sanofi EUR 30.95B 3.09B Dec/2025
UCB EUR 6.05B 733M Dec/2025